TY - JOUR
T1 - Treating heart failure in older and oldest old patients
AU - Vetrano, Davide Liborio
AU - Lattanzio, Fabrizia
AU - Martone, Anna Maria
AU - Landi, Francesco
AU - Brandi, Vincenzo
AU - Topinkova, Eva
AU - Onder, Graziano
PY - 2015
Y1 - 2015
N2 - Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacol- ogical and non-pharmacological approaches has determined an improvement in survival of patients with HF, lead- ing to the selection of an older and frailer population with HF. The clinical approach to such a complex population should require clear indications to assist physicians during their daily practice, but there is a huge lack of evidence regarding the treatment of HF in the oldest among the elderly patient population. In addition, the co-occurrence of specific conditions that are extremely prevalent in older individuals with HF, such as cognitive impairment, co-morbidities, and polypharmacy, can further complicate the clinical man agement of this condition. Thus, a Davide Liborio Vetrano multidisciplinary approach with the goal of recognizing and treating conditions associated with HF may be necessary to improve the quality of care and to reduce expenditures. Several studies have assessed the effect of a comprehensive geriatric assessment and management on quality of care in HF patients, demonstrating a substantial improvement in patient outcomes and administration of the appropriate drug treatment.
AB - Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacol- ogical and non-pharmacological approaches has determined an improvement in survival of patients with HF, lead- ing to the selection of an older and frailer population with HF. The clinical approach to such a complex population should require clear indications to assist physicians during their daily practice, but there is a huge lack of evidence regarding the treatment of HF in the oldest among the elderly patient population. In addition, the co-occurrence of specific conditions that are extremely prevalent in older individuals with HF, such as cognitive impairment, co-morbidities, and polypharmacy, can further complicate the clinical man agement of this condition. Thus, a Davide Liborio Vetrano multidisciplinary approach with the goal of recognizing and treating conditions associated with HF may be necessary to improve the quality of care and to reduce expenditures. Several studies have assessed the effect of a comprehensive geriatric assessment and management on quality of care in HF patients, demonstrating a substantial improvement in patient outcomes and administration of the appropriate drug treatment.
KW - Elderly
KW - Heart failure
KW - Multidimensional approach
KW - Oldest old
KW - Polypharmacy
UR - http://www.scopus.com/inward/record.url?scp=84930894726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930894726&partnerID=8YFLogxK
M3 - Article
C2 - 25633115
AN - SCOPUS:84930894726
VL - 21
SP - 1659
EP - 1664
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
SN - 1381-6128
IS - 13
ER -